Sensitivity and specificity of CRP for predicting lung cancer was both 61% when using a cut-point of 2.1 mg l−1, whereas corresponding values for YKL-40 in risk prediction of gastrointestinal cancer were 63% using a cut-point of 69.0 μg l−1. This evidence concerns the gene CRP and lung cancer.